138 related articles for article (PubMed ID: 16893081)
1. Disease-associated sequence variations in factor H: a structural biology approach.
Herbert AP; Soares DC; Pangburn MK; Barlow PN
Adv Exp Med Biol; 2006; 586():313-27. PubMed ID: 16893081
[No Abstract] [Full Text] [Related]
2. Complement factor H: using atomic resolution structure to illuminate disease mechanisms.
Barlow PN; Hageman GS; Lea SM
Adv Exp Med Biol; 2008; 632():117-42. PubMed ID: 19025119
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.
Clark SJ; Ridge LA; Herbert AP; Hakobyan S; Mulloy B; Lennon R; Würzner R; Morgan BP; Uhrín D; Bishop PN; Day AJ
J Immunol; 2013 Mar; 190(5):2049-57. PubMed ID: 23365078
[TBL] [Abstract][Full Text] [Related]
4. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.
Nan R; Gor J; Perkins SJ
J Mol Biol; 2008 Jan; 375(4):891-900. PubMed ID: 18054958
[TBL] [Abstract][Full Text] [Related]
5. [The role of complement in physiology and pathology].
Klaska I; Nowak JZ
Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
[TBL] [Abstract][Full Text] [Related]
6. Creating functional sophistication from simple protein building blocks, exemplified by factor H and the regulators of complement activation.
Makou E; Herbert AP; Barlow PN
Biochem Soc Trans; 2015 Oct; 43(5):812-8. PubMed ID: 26517887
[TBL] [Abstract][Full Text] [Related]
7. The human complement factor H: functional roles, genetic variations and disease associations.
Rodríguez de Córdoba S; Esparza-Gordillo J; Goicoechea de Jorge E; Lopez-Trascasa M; Sánchez-Corral P
Mol Immunol; 2004 Jun; 41(4):355-67. PubMed ID: 15163532
[TBL] [Abstract][Full Text] [Related]
8. Factor H family proteins and human diseases.
Józsi M; Zipfel PF
Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
[TBL] [Abstract][Full Text] [Related]
9. Complement factor H and the hemolytic uremic syndrome.
Atkinson JP; Goodship TH
J Exp Med; 2007 Jun; 204(6):1245-8. PubMed ID: 17548524
[TBL] [Abstract][Full Text] [Related]
10. Complement regulators in human disease: lessons from modern genetics.
Liszewski MK; Atkinson JP
J Intern Med; 2015 Mar; 277(3):294-305. PubMed ID: 25495259
[TBL] [Abstract][Full Text] [Related]
11. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
12. Atypical hemolytic uremic syndrome.
Kavanagh D; Goodship TH
Curr Opin Hematol; 2010 Sep; 17(5):432-8. PubMed ID: 20613506
[TBL] [Abstract][Full Text] [Related]
13. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
Roumenina LT; Roquigny R; Blanc C; Poulain N; Ngo S; Dragon-Durey MA; Frémeaux-Bacchi V
Methods Mol Biol; 2014; 1100():237-47. PubMed ID: 24218264
[TBL] [Abstract][Full Text] [Related]
14. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.
Buddles MR; Donne RL; Richards A; Goodship J; Goodship TH
Am J Hum Genet; 2000 May; 66(5):1721-2. PubMed ID: 10762557
[No Abstract] [Full Text] [Related]
15. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?
Zipfel PF
Trends Immunol; 2001 Jul; 22(7):345-8. PubMed ID: 11429311
[TBL] [Abstract][Full Text] [Related]
17. The role of complement in AMD.
Zipfel PF; Lauer N; Skerka C
Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
[TBL] [Abstract][Full Text] [Related]
18. Alternative complement pathway assessment in patients with atypical HUS.
Roumenina LT; Loirat C; Dragon-Durey MA; Halbwachs-Mecarelli L; Sautes-Fridman C; Fremeaux-Bacchi V
J Immunol Methods; 2011 Feb; 365(1-2):8-26. PubMed ID: 21215749
[TBL] [Abstract][Full Text] [Related]
19. Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant.
Lauer N; Mihlan M; Hartmann A; Schlötzer-Schrehardt U; Keilhauer C; Scholl HP; Charbel Issa P; Holz F; Weber BH; Skerka C; Zipfel PF
J Immunol; 2011 Oct; 187(8):4374-83. PubMed ID: 21930971
[TBL] [Abstract][Full Text] [Related]
20. Age-related macular degeneration: Complement in action.
van Lookeren Campagne M; Strauss EC; Yaspan BL
Immunobiology; 2016 Jun; 221(6):733-9. PubMed ID: 26742632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
